Capricor Therapeutics (CAPR) Peer Comparison

$9.52

$0.24 (2.53%)

As on 04-Sep-2026 13:36EDT

Market cap

$585 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

2.4

Div. Yield

0 %

Edit

	Capricor Therapeutics (CAPR)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Madrigal Pharmaceuticals (MDGL)
Market cap ($ Mln)	585	16,765	16,261	13,492	12,332
Revenue ($ Mln)	--	2,782	1,054	2,436	1,284
Net Profit ($ Mln)	-129.42	491.50	755.85	860.62	-325.10
Net Margin (%)	--	17.67	71.69	35.33	-25.32
RoE (%)	-46.89	110.09	--	42.98	-57.72
Price to Earnings	--	35.25	19.00	17.40	--
Price-To-Book	2.38	39.29	9.76	7.42	23.98

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	Capricor Therapeutics (CAPR)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Madrigal Pharmaceuticals (MDGL)
Operating Revenue	0.00	2,782.29	1,054.37	2,435.92	1,283.94
Cost of Revenue	20.36	1,982.07	103.47	85.67	109.42
Gross Profit	--	760.62	588.53	2,236.43	902.26
Operating Expenses	114.80	216.81	841.45	1,378.74	1,497.13
Operating Profit (EBIT)	-135.16	583.40	109.45	971.51	-322.62
Other Income	0.00	0.00	0.00	0.00	0.00
Profit before Tax	-129.41	598.92	101.11	1,035.47	-325.10
Provision for Tax	0.00	107.42	-654.74	174.84	0.00
Profit after Tax (Net Income)	-129.42	491.50	755.85	860.62	-325.10
Minority Interest	0.00	0.00	0.00	0.00	0.00
Consolidated Profit	0.00	0.00	0.00	0.00	0.00

Liabilities ($ Mln)

	Capricor Therapeutics (CAPR)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Madrigal Pharmaceuticals (MDGL)
Shareholder's Funds	246.22	433.86	1,435.90	1,843.76	523.72
Minority Interest	0.00	0.00	0.00	0.00	0.00
Non-Current Liabilities	89.56	187.89	384.48	288.55	346.72
Current Liabilities	32.96	1,435.43	464.70	361.93	374.20
Total Liabilities	355.95	1,975.47	1,302.02	2,844.42	1,259.59

Assets ($ Mln)

	Capricor Therapeutics (CAPR)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Madrigal Pharmaceuticals (MDGL)
Non-Current Assets	126.61	1,006.90	895.24	1,243.41	45.47
Current Assets	242.13	1,050.29	1,389.84	1,250.82	1,199.18
Total Assets	355.95	1,975.47	1,302.02	2,844.42	1,259.59
Total Debt*	91.05	120.10	449.89	165.93	347.75
Net Current Assets	0.00	-385.14	0.00	888.90	824.98

Cashflow ($ Mln)

	Capricor Therapeutics (CAPR)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Madrigal Pharmaceuticals (MDGL)
Cash From Operating Activities	-69.81	713.22	51.77	884.27	-189.55
Cash Flow from Investing Activities	97.48	-31.14	-8.15	350.44	32.32
Cash from Financing Activities	248.89	-860.39	34.89	-969.59	255.98
Net Cash Inflow / Outflow	--	--	--	--	--

Ratios

Profitability Ratios

	Capricor Therapeutics (CAPR)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Madrigal Pharmaceuticals (MDGL)
ROCE (%)	-44.32	53.56	-30.01	32.82	-31.49
ROE (%)	-46.89	110.09	163.18	42.98	-57.72
ROA (%)	-33.49	15.64	26.53	29.32	-22.97
EBIT Margin (%)	--	21.13	5.73	31.04	-18.97
Net Margin (%)	--	17.67	71.69	35.33	-25.32
Cash Profit Margin (%)	--	0.00	0.00	0.00	0.00

Growth Ratios

	Capricor Therapeutics (CAPR)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Madrigal Pharmaceuticals (MDGL)
Revenue Growth (%)	-1.00	24.67	114.85	9.23	149.04
EBIT Growth (%)	-80.59	18.70	136.39	-3.99	9.16
Net Profit Growth (%)	-84.94	17.50	378.76	42.89	-15.32
EPS Growth (%)	-45.54	26.84	353.27	50.42	-0.64
Book Value Growth (%)	85.08	164.02	816.12	-0.70	-42.66

Valuation Ratios

	Capricor Therapeutics (CAPR)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Madrigal Pharmaceuticals (MDGL)
Price / Earnings	-13.42	36.06	-59.76	15.79	-45.32
Price / Book Value	4.61	35.44	-80.42	5.72	21.68
Dividend Yield (%)	--	--	--	--	--
EV/EBITDA	-11.08	28.08	-121.54	12.44	-47.02
Market Cap ($ Cr)	--	--	--	--	--

Solvency Ratios

	Capricor Therapeutics (CAPR)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Madrigal Pharmaceuticals (MDGL)
Debt to Equity	0.00	0.00	0.00	0.00	0.65
Short term debt to equity ratio	0.01	0.00	0.05	0.00	0.00
Current Ratio	7.35	0.73	2.99	3.46	3.20
Quick Ratio	7.35	0.73	2.32	3.38	2.94
Interest Coverage	-41.49	--	1.62	--	-19.80

Operating Efficiency Ratios

	Capricor Therapeutics (CAPR)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Madrigal Pharmaceuticals (MDGL)
Debtors to sales (%)	--	15.88	21.25	13.74	14.98
Asset Turnover	0.00	0.89	0.37	0.83	0.91
Receivable days	--	50.42	85.52	43.48	35.88
Inventory Days	--	--	1,056.70	96.17	354.23
Payable days	--	6.26	331.01	147.97	300.79
Cash Conversion Cycle	--	--	811.21	-8.32	89.33

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly